Toyama Chemical Co. is conducting a clinical research study to evaluate an investigational treatment for patients with Mild to Moderate Alzheimer's disease. Participants will receive study related exams, lab work, memory tests, and study drug at no charge. You may qualify if you are:
- Are between the ages of 50 and 90 years old.
- Have mild to moderate Alzheimer's disease
- Are currently receiving Aricept (donepezil), but no other Alzheimer’s Disease therapy.
- Are living in the community and have a caregiver willing to attend each study visit.
More detailed information can be found at: http://www.clinicaltrials.gov/ct2/show/NCT00663936
Or contact one of the participating sites below.
Mark DiBuono, MD
Richmond Behavioral Associates
Staten Island, New York
Contact:
Tatiana Kundla
718-317-5522
patakyova@rbany.com
Zonioviy Benzar, MD
Brooklyn, New York
Contact : Marina Mazur
718-399-7711
Eric Bauer
Team Leader/ Sr. CRA
MDS Pharma Services
Home Office: 512-264-9851
Fax: 512-264-9853
Mobile: 512-796-6994
|
